DAVITA INC. Health Care Organization, Other Revenue (Deprecated 2018-01-31)
DAVITA INC. (DVA) reported Health Care Organization, Other Revenue (Deprecated 2018-01-31) of $232.82 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Income Statement › Other Income
us-gaap:HealthCareOrganizationOtherRevenue · last filed 2018-05-03
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $232.82M, a 26.21% decline year-over-year.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $405.12M, a 2.39% decline year-over-year.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $283.97M, a 14.05% decline year-over-year.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $288.42M, a 16.54% decline year-over-year.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for fiscal 2017 was $1.27B, a 10.14% decline from fiscal 2016.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for fiscal 2016 was $1.41B, a 13.85% increase from fiscal 2015.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for fiscal 2015 was $1.24B, a 20.08% increase from fiscal 2014.
- DAVITA INC. health care organization, other revenue (deprecated 2018-01-31) for fiscal 2014 was $1.03B, a 35.29% increase from fiscal 2013.
| Period end | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 3 month | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 3 month as first filed | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 6 month | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 6 month as first filed | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 9 month | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 9 month as first filed | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 12 month | Health Care Organization, Other Revenue (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $232.82M 10-Q · filed 2018-05-03 | $637.95M derived: sum of 2 quarters · filed 2018-05-03 | $921.92M derived: sum of 3 quarters · filed 2018-05-03 | $1.21B derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-12-31 | $405.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $689.09M derived: sum of 2 quarters · filed 2018-02-23 | $977.51M derived: sum of 3 quarters · filed 2018-02-23 | $1.27B 10-K · filed 2018-02-23 | ||||
| 2017-09-30 | $283.97M 10-Q · filed 2017-11-07 | $572.39M derived: sum of 2 quarters · filed 2017-11-07 | $863.24M 10-Q · filed 2017-11-07 | $1.30B derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-06-30 | $288.42M 10-Q · filed 2017-08-01 | $579.27M 10-Q · filed 2017-08-01 | $1.02B derived: sum of 3 quarters · filed 2018-05-03 | $1.35B derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-03-31 | $315.52M 10-Q · filed 2018-05-03 | $290.85M 10-Q · filed 2017-05-02 | $730.56M derived: sum of 2 quarters · filed 2018-05-03 | $1.06B derived: sum of 3 quarters · filed 2018-05-03 | $1.41B derived: sum of 4 quarters · filed 2018-05-03 | |||
| 2016-12-31 | $415.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $745.44M derived: sum of 2 quarters · filed 2018-02-23 | $1.09B derived: sum of 3 quarters · filed 2018-02-23 | $1.41B 10-K · filed 2018-02-23 | $1.32B 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $330.40M 10-Q · filed 2017-11-07 | $347.18M 10-Q · filed 2016-11-02 | $675.98M derived: sum of 2 quarters · filed 2017-11-07 | $996.38M 10-Q · filed 2017-11-07 | $1.03B 10-Q · filed 2016-11-02 | $1.37B derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-06-30 | $345.58M 10-Q · filed 2017-08-01 | $360.60M 10-Q · filed 2016-08-08 | $665.98M 10-Q · filed 2017-08-01 | $686.15M 10-Q · filed 2016-08-08 | $1.04B derived: sum of 3 quarters · filed 2018-02-23 | $1.33B derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $321.36M 10-Q · filed 2017-05-02 | $325.56M 10-Q · filed 2016-05-04 | $691.22M derived: sum of 2 quarters · filed 2018-02-23 | $985.45M derived: sum of 3 quarters · filed 2018-02-23 | $1.30B derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $369.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $664.09M derived: sum of 2 quarters · filed 2018-02-23 | $974.90M derived: sum of 3 quarters · filed 2018-02-23 | $1.24B 10-K · filed 2018-02-23 | $1.22B 10-K · filed 2016-02-26 | |||
| 2015-09-30 | $294.24M 10-Q · filed 2016-11-02 | $605.05M derived: sum of 2 quarters · filed 2016-11-02 | $869.85M 10-Q · filed 2016-11-02 | $1.14B derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | $310.81M 10-Q · filed 2016-08-08 | $575.61M 10-Q · filed 2016-08-08 | $850.03M derived: sum of 3 quarters · filed 2017-02-24 | $1.11B derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $264.80M 10-Q · filed 2016-05-04 | $539.21M derived: sum of 2 quarters · filed 2017-02-24 | $798.93M derived: sum of 3 quarters · filed 2017-02-24 | $1.07B derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $274.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $534.13M derived: sum of 2 quarters · filed 2017-02-24 | $808.05M derived: sum of 3 quarters · filed 2017-02-24 | $1.03B 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $259.72M 10-Q · filed 2015-11-05 | $533.64M derived: sum of 2 quarters · filed 2015-11-05 | $757.95M 10-Q · filed 2015-11-05 | $978.64M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $273.92M 10-Q · filed 2015-08-05 | $498.23M 10-Q · filed 2015-08-05 | $718.93M derived: sum of 3 quarters · filed 2016-02-26 | $919.03M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $224.31M 10-Q/A · filed 2015-05-08 | $445.01M derived: sum of 2 quarters · filed 2016-02-26 | $645.11M derived: sum of 3 quarters · filed 2016-02-26 | $830.25M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $220.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $420.80M derived: sum of 2 quarters · filed 2016-02-26 | $605.93M derived: sum of 3 quarters · filed 2016-02-26 | $763.09M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $200.10M 10-Q · filed 2014-11-06 | $385.24M derived: sum of 2 quarters · filed 2014-11-06 | $542.39M 10-Q · filed 2014-11-06 | $721.95M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $185.14M 10-Q · filed 2014-08-01 | $202.86M 10-Q · filed 2013-08-07 | $342.29M 10-Q · filed 2014-08-01 | $376.55M 10-Q · filed 2013-08-07 | $521.85M derived: sum of 3 quarters · filed 2015-02-26 | $668.34M derived: sum of 4 quarters · filed 2015-02-26 | ||
| 2013-03-31 | $157.15M 10-Q · filed 2014-05-02 | $173.69M 10-Q · filed 2013-05-09 | $336.71M derived: sum of 2 quarters · filed 2015-02-26 | $483.20M derived: sum of 3 quarters · filed 2015-02-26 | $636.89M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2012-12-31 | $179.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $326.05M derived: sum of 2 quarters · filed 2015-02-26 | $479.74M derived: sum of 3 quarters · filed 2015-02-26 | $588.26M 10-K · filed 2015-02-26 | $650.17M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $146.50M 10-Q · filed 2013-11-06 | $184.41M 10-Q · filed 2012-10-31 | $300.18M derived: sum of 2 quarters · filed 2013-11-06 | $408.70M 10-Q · filed 2013-11-06 | $516.37M 10-Q · filed 2012-10-31 | $473.18M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-06-30 | $153.68M 10-Q · filed 2013-08-07 | $174.90M 10-Q · filed 2012-08-03 | $290.74M 10-Q · filed 2013-08-07 | $331.96M 10-Q · filed 2012-08-03 | $326.68M derived: sum of 3 quarters · filed 2014-02-21 | $465.46M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-03-31 | $137.06M 10-Q · filed 2013-05-09 | $155.94M 10-Q · filed 2012-05-02 | $173.00M derived: sum of 2 quarters · filed 2014-02-21 | $311.78M derived: sum of 3 quarters · filed 2014-02-21 | $437.48M derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2011-12-31 | $35.94M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $174.72M derived: sum of 2 quarters · filed 2014-02-21 | $300.42M derived: sum of 3 quarters · filed 2014-02-21 | $406.37M 10-K · filed 2014-02-21 | $519.40M 8-K · filed 2012-07-06 | |||
| 2011-09-30 | $138.78M 10-Q · filed 2012-10-31 | $264.48M derived: sum of 2 quarters · filed 2012-10-31 | $370.43M 10-Q · filed 2012-10-31 | |||||
| 2011-06-30 | $125.69M 10-Q · filed 2012-08-03 | $231.64M 10-Q · filed 2012-08-03 | ||||||
| 2011-03-31 | $105.95M 10-Q · filed 2012-05-02 | |||||||
| 2010-12-31 | $336.64M 10-K · filed 2013-03-01 | $394.51M 8-K · filed 2012-07-06 | ||||||
| 2009-12-31 | $342.70M 8-K · filed 2012-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |